| 2023 | 2022 | |||||||
| For the Years Ended December 31, | ||||||||
| 2023 | 2022 | |||||||
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net loss | $ | (11,264) | $ | (14,407) | ||||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
| Depreciation | 257 | 323 | ||||||
| Stock-based compensation | 589 | 581 | ||||||
| Non-cash operating leases | 614 | 225 | ||||||
| Loss on disposal of fixed assets | - | 43 | ||||||
| Loss on sale of marketable securities | - | 2 | ||||||
| Gain from PPP loan forgiveness | - | (1,038) | ||||||
| Change in fair value of SAFEs | 1,736 | - | ||||||
| Change in fair value of redeemable convertible preferred stock warrant liability | (4,950) | 2,515 | ||||||
| Change in fair value of warrant liability | ||||||||
| Change in operating assets and liabilities | ||||||||
| Prepaid expenses and other current assets | (139) | 284 | ||||||
| Prepaid expenses | ||||||||
| Other assets | - | 138 | ||||||
| Accounts payable | 790 | 44 | ||||||
| Accrued expenses and other current liabilities | (728) | (186) | ||||||
| Accounts payable – related party | (18) | 60 | ||||||
| Operating lease liabilities | (603) | (226) | ||||||
| Net cash used in operating activities | (13,716) | (11,642) | ||||||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Purchases of property and equipment | (65) | (41) | ||||||
| Purchases of marketable securities | - | (594) | ||||||
| Proceeds from disposal of property and equipment | - | 95 | ||||||
| Proceeds from maturities of marketable securities | - | 594 | ||||||
| Proceeds from sales of marketable securities | - | 870 | ||||||
| Net cash from business combination | 15,605 | - | ||||||
| Net cash provided by investing activities | 15,540 | 924 | ||||||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Proceeds from exercise of employee stock options | 5 | 79 | ||||||
| Proceeds from issuance of redeemable convertible preferred stock and warrants, net of issuance costs | 3,983 | 5,810 | ||||||
| Repayment of finance lease liabilities | (63) | - | ||||||
| Proceeds from the issuance of the SAFE agreements, net | 3,897 | 4,009 | ||||||
| Net cash provided by financing activities | 7,822 | 9,898 | ||||||
| Net increase (decrease) in cash and cash equivalents | 9,646 | (820) | ||||||
| Effect of exchange rate changes on cash | 598 | |||||||
| Cash and cash equivalents at the beginning of the year | 1,581 | 2,401 | ||||||
| Cash and cash equivalents at the end of the year | $ | 11,825 | $ | 1,581 | ||||
| SUPPLEMENTAL DISCLOSURE OF NON-CASH FINANCING ACTIVITIES: | ||||||||
| Issuance of finance lease liability for finance lease right-of-use asset | $ | 405 | $ | - | ||||
| Issuance of operating lease liability for operating lease right-of-use asset | $ | 1,950 | $ | 181 | ||||
| Issuance of ordinary shares for conversion of Series A redeemable convertible preferred stock | $ | 6,653 | $ | - | ||||
| Issuance of ordinary shares for conversion of Series B redeemable convertible preferred stock | $ | 21,440 | $ | - | ||||
| Issuance of ordinary shares for conversion of Series C redeemable convertible preferred stock | $ | 7,259 | $ | - | ||||
| Issuance of ordinary shares for anti-dilution shares related to Series A, B, C, and D redeemable | ||||||||
| convertible preferred stock | $ | 166 | $ | - | ||||
| Issuance of ordinary shares for anti-dilution shares related to Series A, B, C, and D redeemable convertible preferred stock | 166 | - | ||||||
| Issuance of ordinary shares for incentive shares related to Series A, B, C, and D redeemable | ||||||||
| convertible preferred stock | $ | 230 | $ | - | ||||
| Issuance of ordinary shares for incentive shares related to Series A, B, C, and D redeemable convertible preferred stock | 230 | - | ||||||
| Issuance of ordinary shares for conversion of SAFEs | $ | 7,880 | $ | - | ||||
| Fair value allocated at issuance to Series C warrants | $ | - | $ | 2,053 | ||||
| Series C redeemable convertible preferred stock issuance costs in accrued expenses | $ | - | $ | 38 | ||||
| Conversion of Series A and Series B redeemable convertible preferred stock to common stock | $ | - | $ | 30,722 | ||||
